Free cancer support
liver cancer
Liver cancer refers to malignant tumors originating in liver tissue and is one of the leading causes of liver-related deaths worldwide. Liver cancer can be classified into primary liver cancer (originating in the liver) and secondary liver cancer (metastatic from other organs), with hepatocellular carcinoma (HCC) being the most common type.
High-risk factors for liver cancer include:
Chronic liver disease: such as chronic hepatitis B or C, and liver cirrhosis
Lifestyle factors: long-term alcohol consumption, obesity, diabetes
Environmental factors: prolonged exposure to carcinogens like aflatoxins
Family history: individuals with a family history of liver cancer are at higher risk
Because early-stage liver cancer often shows no obvious symptoms, regular liver function tests and imaging screenings are crucial for high-risk populations.
Early-stage liver cancer may not show obvious symptoms. As the disease progresses, patients may experience:
Upper abdominal discomfort or pain: often located in the right upper abdomen, sometimes accompanied by bloating
Loss of appetite and weight loss
General symptoms: fatigue, weakness, or low-grade fever
Yellowing of skin and eyes: jaundice caused by elevated bilirubin
Ascites or enlarged liver: advanced patients may experience abdominal swelling or fluid accumulation
Other symptoms: nausea, vomiting, tendency to bleed, or bruising
Early symptoms are often subtle, so regular screening is essential for high-risk individuals to detect liver cancer at an early stage.
Diagnosis of liver cancer relies on multiple examination methods:
Imaging examinations
Ultrasound (US): initial assessment of liver lesions
CT / MRI: visualize tumor size, location, and vascular invasion
PET-CT: evaluate potential distant metastasis
Blood tests
Tumor markers (e.g., AFP, alpha-fetoprotein) can assist in diagnosis and monitor treatment response
Histological examination (biopsy)
Liver tissue may be obtained for microscopic analysis when necessary to confirm tumor type and staging
Molecular and genetic testing
Analyze tumor gene mutations to guide personalized care and supportive strategies
Management of liver cancer can include surgery, interventional therapies, targeted/immunological support, and personalized care, aiming to slow disease progression and improve quality of life:
Surgery and hepatic resection
Early tumors can be removed surgically
Postoperative nutrition support and care plans can accelerate recovery
Interventional therapies
Includes transarterial chemoembolization (TACE), radiofrequency ablation (RFA), etc.
Suitable for patients who are not candidates for surgery and can help control tumor growth
Targeted and immune support
Personalized care plans based on molecular testing
Nutrition support and immune-enhancing therapies can strengthen patient resistance
Nutrition and supportive treatments
High-dose vitamin C, amino acids, glutathione, and trace element infusions
Improve energy levels, maintain immune function, and support overall health
Personalized monitoring and care
Regular imaging and blood tests to monitor disease progression
Adjust care plans, nutrition, lifestyle, and psychological support accordingly
High-risk populations, such as patients with chronic hepatitis or cirrhosis, can receive specialized long-term care plans
